Related references
Note: Only part of the references are listed.Niche Modulation of IGF-1R Signaling: Its Role in Stem Cell Pluripotency, Cancer Reprogramming, and Therapeutic Applications
Pei-Chin Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
The potential and controversy of targeting STAT family members in cancer
Yannick Verhoeven et al.
SEMINARS IN CANCER BIOLOGY (2020)
Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma
Yingnan Ye et al.
CANCER LETTERS (2020)
IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway
Qiang Guo et al.
DIGESTIVE AND LIVER DISEASE (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Initial Experience of Ramucirumab Treatment After Lenvatinib Failure for Patients With Advanced Hepatocellular Carcinoma
Teiji Kuzuya et al.
ANTICANCER RESEARCH (2020)
Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive Biomarker
Chang Min Kim et al.
LIVER CANCER (2020)
Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression
Rongdang Fu et al.
MEDICAL ONCOLOGY (2020)
Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies
Chia-Jui Yen et al.
LIVER CANCER (2020)
Aquaporin-9, Mediated by IGF2, Suppresses Liver Cancer Stem Cell Properties via Augmenting ROS/β-Catenin/FOXO3a Signaling
Xi Zheng et al.
MOLECULAR CANCER RESEARCH (2020)
Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence
Emmanuele De Luca et al.
CANCER MANAGEMENT AND RESEARCH (2020)
The Cancer Stem Cell in Hepatocellular Carcinoma
Lucas-Alexander Schulte et al.
CANCERS (2020)
Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
Li Jin et al.
FRONTIERS IN ONCOLOGY (2020)
An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness
Mei-Yu Quan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Cabozantinib for the Treatment of Advanced Hepatocellular Carcinoma: Current Data and Future Perspectives
Joerg Trojan
DRUGS (2020)
Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
Weiwei Shi et al.
FRONTIERS IN ONCOLOGY (2020)
Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019–40: a modelling study
Jovan Julien et al.
Lancet Public Health (2020)
Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy
Hui Hua et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma
Yanan Gao et al.
PHARMACOLOGICAL RESEARCH (2020)
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
Weiwei Tang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment
Srikanta Dash et al.
JOURNAL OF HEPATOCELLULAR CARCINOMA (2020)
Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma
Xian Lin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells
Lin-wen Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma
Ruiqi Liu et al.
CANCER LETTERS (2019)
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
Matthias Van Haele et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Distribution of insulin growth factor-1 (IGF-1) binding proteins in hepatocellular carcinoma with and without cirrhosis.
Ahmed Abdelhakeem et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Nathalie Ganne-Carrie et al.
JOURNAL OF HEPATOLOGY (2019)
Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model
Alastair Heffernan et al.
LANCET (2019)
Cabozantinib: A Review in Advanced Hepatocellular Carcinoma
Emma D. Deeks
TARGETED ONCOLOGY (2019)
Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
Myriam Alexander et al.
BMC MEDICINE (2019)
A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA
Jia He et al.
CANCER LETTERS (2019)
Insulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell features
Eva Benabou et al.
CANCER LETTERS (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5
Xiaoyu Weng et al.
EBIOMEDICINE (2019)
HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models
Joseph Torresi et al.
BMC CANCER (2019)
Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers
Tze-Sian Chan et al.
FRONTIERS IN ONCOLOGY (2019)
Enhancer of zeste 2 polycomb repressive complex 2 subunit promotes sorafenib resistance of hepatocellular carcinoma though insulin-like growth factor 1 receptor
Jing Hu et al.
ANTI-CANCER DRUGS (2019)
Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers
Flavia Fondevila et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Dedifferentiation process driven by radiotherapy-induced HMGB1/TLR2/YAP/HIF-1α signaling enhances pancreatic cancer stemness
Lirong Zhang et al.
CELL DEATH & DISEASE (2019)
Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis
Bixing Zhao et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
Shigeki Suemura et al.
CANCERS (2019)
LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
T Yau et al.
ANNALS OF ONCOLOGY (2019)
DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
Ssu-Chuan Lai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The Hippo pathway integrates PI3K-Akt signals with mechanical and polarity cues to control tissue growth
Nerea Borreguero-Munoz et al.
PLOS BIOLOGY (2019)
MicroRNA-28-5p Regulates Liver Cancer Stem Cell Expansion via IGF-1 Pathway
Qing Xia et al.
STEM CELLS INTERNATIONAL (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and ReIB in vitro
Diana M. Elizondo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC (Review)
Lige Qiu et al.
ONCOLOGY LETTERS (2018)
Identification of a unique loss-of-function mutation in IGF1R and a crosstalk between IGF1R and Wnt/β-catenin signaling pathways
Gayatri Jamwal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma
Anthony B. El-Khoueiry et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Multikinase Inhibitor CT-707 Targets Liver Cancer by Interrupting the Hypoxia-Activated IGF-1R-YAP Axis
Hong Zhu et al.
CANCER RESEARCH (2018)
Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells
Yuanyuan Ji et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT
Jie Mao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Hepatitis B virus suppresses the secretion of insulin-like growth factor binding protein 1 to facilitate anti-apoptotic IGF-1 effects in HepG2 cells
Kirstine Overgaard Nielsen et al.
EXPERIMENTAL CELL RESEARCH (2018)
Insulin-Like Growth Factor (IGF) System in Liver Diseases
Agnieszka Adamek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells
Maria Grazia Refolo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Association between non-alcoholic fatty liver disease and cancer incidence rate
Gi-Ae Kim et al.
JOURNAL OF HEPATOLOGY (2018)
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
IGF1 receptor signaling pathways
Fumihiko Hakuno et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
Chung-Kwe Wang
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis
Ying-Ying Lee et al.
NUCLEIC ACIDS RESEARCH (2018)
Insulin-like growth factor-1 induces epithelial-mesenchymal transition in hepatocellular carcinoma by activating survivin
Fangfeng Liu et al.
ONCOLOGY REPORTS (2018)
Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro
Hang-Lung Chang et al.
TOXICOLOGY IN VITRO (2018)
Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus
Dvora Witt-Kehati et al.
TRANSLATIONAL ONCOLOGY (2018)
Mechanisms of Hepatitis B Virus Persistence
Kuen-Nan Tsai et al.
TRENDS IN MICROBIOLOGY (2018)
Interplay between inflammatory tumor microenvironment and cancer stein cells (Review)
Shijian Zhang et al.
ONCOLOGY LETTERS (2018)
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types
Prashant D. Tailor et al.
Oncotarget (2018)
IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
John B. Allard et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Insulin-Like Growth Factor Binding Proteins and IGFBP Proteases A Dynamic System Regulating the Ovarian Folliculogenesis
Sabine Mazerbourg et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort
Yvonne Huber et al.
BMC CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
Sox2 is associated with cancer stem-like properties in colorectal cancer
Koki Takeda et al.
SCIENTIFIC REPORTS (2018)
Inhibition of Insulin-Like Growth Factor 1 Receptor Enhances the Efficacy of Sorafenib in Inhibiting Hepatocellular Carcinoma Cell Growth and Survival
Fang Wang et al.
HEPATOLOGY COMMUNICATIONS (2018)
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
Victoria Tovar et al.
GUT (2017)
IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture
V. J. Lara-Diaz et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Influence of higher BMI for hepatitis B- and C-related hepatocellular carcinomas
Masakazu Hashimoto et al.
LANGENBECKS ARCHIVES OF SURGERY (2017)
Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells
Catharina Melzer et al.
MOLECULAR CANCER (2017)
Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinoma
Jinjin Yan et al.
ONCOLOGY LETTERS (2017)
Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients
Astrid Marot et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma
Chuanzong Zhao et al.
ONCOTARGET (2017)
C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway
Rachel Hiu Ha Ching et al.
ONCOTARGET (2017)
The Roles of Insulin-Like Growth Factors in Mesenchymal Stem Cell Niche
Amer Youssef et al.
STEM CELLS INTERNATIONAL (2017)
Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period
R. Pais et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
IGFBP7 Deletion Promotes Hepatocellular Carcinoma
Maaged Akiel et al.
CANCER RESEARCH (2017)
The virological aspects of hepatitis B
Zina S. Valaydon et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling
E. Sanchez-Lopez et al.
ONCOGENE (2016)
RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer
Y. Qiao et al.
ONCOGENE (2016)
AMPK interacts with β-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment
Song Yi Park et al.
ONCOLOGY REPORTS (2016)
MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways
Yanmin Xu et al.
CANCER LETTERS (2016)
Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma
T. Vescovo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models
Iris Martinez-Quetglas et al.
GASTROENTEROLOGY (2016)
SIRT1-mediated transcriptional regulation of SOX2 is important for self-renewal of liver cancer stem cells
Limei Liu et al.
HEPATOLOGY (2016)
The Relationship of Insulin-Like Growth Factor 2 to Fetal Growth and Adiposity
Rachel Kadakia et al.
HORMONE RESEARCH IN PAEDIATRICS (2016)
EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes
Saravana Kumar Kailasam Mani et al.
JOURNAL OF HEPATOLOGY (2016)
Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis
Xue Wang et al.
JOURNAL OF HEPATOLOGY (2016)
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
Jeffrey D. Stanaway et al.
LANCET (2016)
Cytokine Changes following Acute Ethanol Intoxication in Healthy Men: A Crossover Study
Sudan Prasad Neupane et al.
MEDIATORS OF INFLAMMATION (2016)
The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network
Il-Chi Chang et al.
MEDICINE (2016)
Protein misfolding in the endoplasmic reticulum as a conduit to human disease
Miao Wang et al.
NATURE (2016)
Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma
Te-Sheng Chang et al.
PLOS ONE (2016)
The role of pluripotency factors to drive stemness in gastrointestinal cancer
Martin Mueller et al.
STEM CELL RESEARCH (2016)
Liver cancer stem cell markers: Progression and therapeutic implications
Jing-Hui Sun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Challenges of advanced hepatocellular carcinoma
Stefano Colagrande et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma
Victor Jeannot et al.
ONCOTARGETS AND THERAPY (2016)
MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc
Rana Ahmed Youness et al.
ONCOLOGY LETTERS (2016)
LncBRM initiates YAP1 signalling activation to drive self-renewal of liver cancer stem cells
Pingping Zhu et al.
NATURE COMMUNICATIONS (2016)
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives
Ricardo Costa et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties
Kai-Yu Ng et al.
ONCOTARGET (2016)
Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells
Yang You et al.
ONCOTARGET (2016)
IGF-II induced by hepatitis B virus X protein regulates EMT via SUMO mediated loss of E- cadherin in mice
Hye-Lin Ha et al.
ONCOTARGET (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways
Haim Werner et al.
FRONTIERS IN ONCOLOGY (2016)
Multitargeting strategy using lenvatinib and golvatinib: Maximizing anti-angiogenesis activity in a preclinical cancer model
Youya Nakazawa et al.
CANCER SCIENCE (2015)
The Long Noncoding RNA IncTCF7 Promotes Self-Renewal of Human Liver Cancer Stem Cells through Activation of Wnt Signaling
Yanying Wang et al.
CELL STEM CELL (2015)
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Vicki Plaks et al.
CELL STEM CELL (2015)
Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression
Te-Sheng Chang et al.
CLINICAL CANCER RESEARCH (2015)
Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1
Catia Lippolis et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Paracrine Factors of Human Fetal MSCs Inhibit Liver Cancer Growth Through Reduced Activation of IGF-1R/PI3K/Akt Signaling
Yulyana Yulyana et al.
MOLECULAR THERAPY (2015)
Daintain/AIF-1 accelerates the activation of insulin-like growth factor-1 receptor signaling pathway in HepG2 cells
Shaohui Jia et al.
ONCOLOGY REPORTS (2015)
Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma
Hend M. El Tayebi et al.
ONCOLOGY LETTERS (2015)
Effect of hypoxia on hypoxia inducible factor-1α, insulin-like growth factor I and vascular endothelial growth factor expression in hepatocellular carcinoma HepG2 cells
Qiang Liu et al.
ONCOLOGY LETTERS (2015)
Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies
Varsha P. Brahmkhatri et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma
Shaohui Tang et al.
LIVER INTERNATIONAL (2015)
IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction
C. Rupp et al.
ONCOGENE (2015)
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
F. Turati et al.
ANNALS OF ONCOLOGY (2014)
Hippo Pathway Activity Influences Liver Cell Fate
Dean Yimlamai et al.
CELL (2014)
STAT3 Mediates Regorafenib-Induced Apoptosis in Hepatocellular Carcinoma
Wei-Tien Tai et al.
CLINICAL CANCER RESEARCH (2014)
Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2014)
Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality
Chun-Jen Liu et al.
GUT (2014)
A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF HEPATOLOGY (2014)
The Complexity of the IGF1 Gene Splicing, Posttranslational Modification and Bioactivity
Anastassios Philippou et al.
MOLECULAR MEDICINE (2014)
Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture
Xingnan Li et al.
NATURE MEDICINE (2014)
Maintenance of Stemness in Oxaliplatin-Resistant Hepatocellular Carcinoma Is Associated with Increased Autocrine of IGF1
Yang Bu et al.
PLOS ONE (2014)
HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH
Samuele De Minicis et al.
PLOS ONE (2014)
The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment
Jun Ye et al.
TUMOR BIOLOGY (2014)
Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells
Minoru Tomizawa et al.
ONCOLOGY LETTERS (2014)
Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling
Wan-Jiun Chen et al.
NATURE COMMUNICATIONS (2014)
Prevalence of Aflatoxin Induced p53 Mutation at Codon 249 (R249s) in Hepatocellular Carcinoma Patients with and without Hepatitis B Surface Antigen (HBsAg)
Salyavit Chittmittrapap et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Insulin-like growth factor-binding protein-6 and cancer
Leon A. Bach et al.
CLINICAL SCIENCE (2013)
Minireview: Nuclear Insulin and Insulin-like Growth Factor-1 Receptors: A Novel Paradigm in Signal Transduction
Rive Sarfstein et al.
ENDOCRINOLOGY (2013)
Epidemiology and natural history of HCV infection
Behzad Hajarizadeh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma
Gi Jeong Kim et al.
PLOS ONE (2013)
HBV Induced HCC: Major Risk Factors from Genetic to Molecular Level
Ambreen Ayub et al.
BIOMED RESEARCH INTERNATIONAL (2013)
The Regulation of IGF-1 Gene Transcription and Splicing during Development and Aging
A. M. Oberbauer
Frontiers in Endocrinology (2013)
HBV Perinatal Transmission
Muhammad Umar et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2013)
Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway
Tao Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review
Donna L. White et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Insulin/IGF signaling drives cell proliferation in part via Yorkie/YAP
Katrin Strassburger et al.
DEVELOPMENTAL BIOLOGY (2012)
The Insulin-Like Growth Factor System in Cancer
S. John Weroha et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2012)
Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
Juanjuan Shan et al.
HEPATOLOGY (2012)
EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
Zakaria Ezzoukhry et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Gefitinib resistance in HCC mahlavu cells: Upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation
Adam S. Bodzin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors
Ivonne Regel et al.
MOLECULAR CANCER (2012)
Excess Body Mass Index and Risk of Liver Cancer: A Nonlinear Dose-Response Meta-Analysis of Prospective Studies
Rui Rui et al.
PLOS ONE (2012)
Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection
Eiman Aleem et al.
ONCOLOGY LETTERS (2012)
Cancer Stem Cells Stemness Transcription Factors Expression Correlates with Breast Cancer Disease Stage
Panagiotis Apostolou et al.
CURRENT STEM CELL RESEARCH & THERAPY (2012)
Insulin-Like Growth Factor Signaling as a Therapeutic Target in Pancreatic Cancer
Simon Rieder et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Cancer Stem Cell Niche: The Place to Be
Tijana Borovski et al.
CANCER RESEARCH (2011)
Insulin-like Growth Factor-Binding Protein-7 Functions as a Potential Tumor Suppressor in Hepatocellular Carcinoma
Dong Chen et al.
CLINICAL CANCER RESEARCH (2011)
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Hasan Korkaya et al.
CLINICAL CANCER RESEARCH (2011)
Hippo signaling: growth control and beyond
Georg Halder et al.
DEVELOPMENT (2011)
A phase I study of AVE1642, a human monoclonal antibody-blocking insulin-like growth factor-1 receptor (IGF-1R), given as a single agent and in combination with sorafenib as first-line therapy in patients with advanced hepatocellular carcinoma (HCC).
S. J. Faivre et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase II study of cixutumumab (IMC-A12, NSC742460; C) in hepatocellular carcinoma (HCC)
G. K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Targeting insulin-like growth factor axis in hepatocellular carcinoma
Jennifer Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Yki/YAP, Sd/TEAD and Hth/MEIS Control Tissue Specification in the Drosophila Eye Disc Epithelium
Tianyi Zhang et al.
PLOS ONE (2011)
Viral hepatitis and HIV co-infection
Vincent Soriano et al.
ANTIVIRAL RESEARCH (2010)
Normal values of serum IGF-1 in adults: results from a Brazilian population
Pedro Weslley Rosario
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2010)
Transcriptional down-regulation of IGFBP-3 in human hepatocellular carcinoma cells is mediated by the binding of TIA-1 to its AT-rich element in the 3′-untranslated region
Kothandharaman Subramaniam et al.
CANCER LETTERS (2010)
Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells
Tamara Aleksic et al.
CANCER RESEARCH (2010)
MicroRNA: Biogenesis, Function and Role in Cancer
Leigh-Ann MacFarlane et al.
CURRENT GENOMICS (2010)
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
The Hepatitis B Virus X Protein Modulates Hepatocyte Proliferation Pathways To Stimulate Viral Replication
Tricia L. Gearhart et al.
JOURNAL OF VIROLOGY (2010)
Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer
A. J. Ryan et al.
BRITISH JOURNAL OF CANCER (2009)
Sorafenib A Review of its Use in Advanced Hepatocellular Carcinoma
Gillian M. Keating et al.
DRUGS (2009)
Cixutumumab
Kevin P. McKian et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-I receptor and insulin receptor
Mark J. Mulvihill et al.
FUTURE MEDICINAL CHEMISTRY (2009)
TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation
Siew Wee Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Daintain/AIF-1 promotes breast cancer proliferation via activation of the NF-κB/cyclin D1 pathway and facilitates tumor growth
Shou Liu et al.
CANCER SCIENCE (2008)
The Expression of Hypoxia-Inducible Factor-1 alpha in Hepatitis B Virus-Related Hepatocellular Carcinoma: Correlation with Patients' Prognosis and Hepatitis B Virus X Protein
Huahong Xie et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Molecular targeted therapies in hepatocellular carcinoma
Josep M. Llovet et al.
HEPATOLOGY (2008)
Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins
Marta Guix et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Oxidative stress in alcoholic liver disease: Role of NADPH oxidase complex
Samele De Minicis et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin-like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis
Jie Cao et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2007)
IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro
Sean C. Bendall et al.
NATURE (2007)
Evaluation and management of obesity-related nonalcoholic fatty liver disease
Clare Nugent et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2007)
IGF1R signalling and its inhibition
J. Riedemann et al.
ENDOCRINE-RELATED CANCER (2006)
Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib
Christele Desbois-Mouthon et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
Huban Kutay et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Cytokines and alcohol
FT Crews et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effects of hepatitis B virus X protein on the development of liver cancer
XD Zhang et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2006)
A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome
M Murakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members
WM Mahoney et al.
BIOCHEMICAL JOURNAL (2005)
IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF)
B Saile et al.
LABORATORY INVESTIGATION (2004)
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
MC Kew
LIVER INTERNATIONAL (2003)
Insulin-like growth factor binding protein proteolysis
RC Bunn et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2003)
Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis
Z Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ
CB Cui et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
CL Thio et al.
LANCET (2002)
Hepatitis C and HIV co-infection: a review
I Maier et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)
Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy
MY Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Insulin-like growth factors and cancer
G Fürstenberger et al.
LANCET ONCOLOGY (2002)
Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway
M Forgues et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The IGF axis and hepatocarcinogenesis
JG Scharf et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm
A Vassilev et al.
GENES & DEVELOPMENT (2001)
Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells
AJ Butt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
